Abstract
Background
Patients with systemic lupus erythematosus (SLE) are at an increased risk of acquiring infections due to the disease itself and the immunosuppressive therapy. Furthermore, infections largely contribute to overall SLE mortality. Vaccinations against preventable diseases are therefore of particular importance for these patients.
Aims
To estimate vaccination frequencies among patients with SLE, we studied patients in a survey and calculated vaccination rates based on their vaccination documents. Patients were recruited from our outpatient clinic during one of their routine visits. For the statistical analysis, they have been stratified by age (≥60 vs. <60 years) for further subgroup analysis due to age-related recommendations for some vaccines.
Results
Among the patients studied (n = 68) we found rather low vaccination rates in particular for the strongly recommended vaccines against pneumococcus and influenza (21% and 49%, respectively). Furthermore, protection rates for important basic vaccinations were found to be low, e. g. pertussis protection for 31% of patients. Beside these findings, we saw age-dependant differences for a variety of vaccines: while the pneumococcus vaccination was more often given to patients ≥60 years, measles, pertussis, diphtheria and hepatitis B vaccinations were found significantly more often in younger patients.
Conclusions
Vaccination rates have to be improved among SLE patients, in particular for vaccines protecting from respiratory tract infections such as pneumococcus and influenza.
Zusammenfassung
Hintergrund
Patienten mit systemischem Lupus erythematodes (SLE) haben aus 2 Gründen ein erhöhtes Infektionsrisiko: durch die Krankheit selbst und durch die erforderliche immunsuppressive Therapie. Darüber hinaus tragen Infektionen wesentlich zur Gesamtmortalität von SLE-Patienten bei, daher sind Impfungen gegen vermeidbare Erkrankungen von besonderer Bedeutung.
Ziele
Die Ermittlung der Impfraten in einer ambulanten Kohorte von SLE-Patienten erfolgte anhand der bei den Patienten vorhandenen Impfdokumente. Die Patienten wurden über unsere rheumatologische Hochschulambulanz während einer ihrer Routinebesuche rekrutiert. Da einige Impfungen altersabhängig empfohlen werden, erfolgte eine statistische Auswertung auch nach dem Lebensalter (≥60 vs. <60 Jahre).
Ergebnisse
Innerhalb des untersuchten Patientenkollektivs (n = 68) fanden sich niedrige Impfraten, insbesondere für die empfohlenen Impfungen gegen Pneumokokken und Influenza (21 bzw. 49 %). Auch die Raten für Standardimpfungen waren niedrig, gegen Pertussis beispielweise lag sie bei 31 %. Altersabhängige Unterschiede zeigten sich darüber hinaus für verschiedene Impfungen: Während die Pneumokokkenimpfung häufiger bei Patienten ≥60 Jahren appliziert worden war, waren jüngere Patienten signifikant häufiger gegen Masern, Pertussis, Diphtherie und Hepatitis B geimpft worden.
Schlussfolgerungen
Die Impfraten für SLE-Patienten müssen verbessert werden, insbesondere für Impfungen gegen Erreger, die den Respirationstrakt betreffen (z. B. Pneumokokken, Influenza).
References
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P et al (2003) Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 82(5):299–308. https://doi.org/10.1097/01.md.0000091181.93122.55
Fors Nieves CE, Izmirly PM (2016) Mortality in systemic lupus erythematosus: an updated review. Curr Rheumatol Rep 18(4):21. https://doi.org/10.1007/s11926-016-0571-2
Fei Y, Shi X, Gan F, Li X, Zhang W, Li M et al (2014) Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 33(1):57–63. https://doi.org/10.1007/s10067-013-2383-3
Bermas BL, Petri M, Goldman D, Mittleman B, Miller MW, Stocks NI et al (1994) T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 14(3):169–177
Ross SC, Densen P (1984) Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 63(5):243–273
Ho A, Barr SG, Magder LS, Petri M (2001) A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. Arthritis Rheum 44(10):2350–2357
Fernández-Castro M, Mellor-Pita S, Citores MJ, Muñoz P, Tutor-Ureta P, Silva L et al (2007) Common variable immunodeficiency in systemic lupus erythematosus. Semin Arthritis Rheum 36(4):238–245. https://doi.org/10.1016/j.semarthrit.2006.09.005
Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22(12):1286–1294. https://doi.org/10.1177/0961203313493032
Bosch X, Guilabert A, Pallares L, Cerveral R, Ramos-Casals M, Bove A et al (2006) Infections in systemic lupus erythematosus: a prospective and controlled study of 110 patients. Lupus 15(9):584–589. https://doi.org/10.1177/0961203306071919
Pryor BD, Bologna SG, Kahl LE (1996) Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arthritis Rheum 39(9):1475–1482
Ruiz-Irastorza G, Olivares N, Ruiz-Arruza I, Martinez-Berriotxoa A, Egurbide MV, Aguirre C (2009) Predictors of major infections in systemic lupus erythematosus. Arthritis Res Ther 11(4):R109. https://doi.org/10.1186/ar2764
Hua C, Barnetche T, Combe B, Morel J (2014) Effect of methotrexate, anti-tumor necrosis factor alpha, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 66(7):1016–1026. https://doi.org/10.1002/acr.22246
van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M et al (2011) EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 70(3):414–422. https://doi.org/10.1136/ard.2010.137216
Schurder J, Goulenok T, Jouenne R, Dossier A, Van Gysel D, Papo T et al (2017) Pneumococcal infection in patients with systemic lupus erythematosus. Joint Bone Spine. https://doi.org/10.1016/j.jbspin.2017.05.012
Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O (2008) Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 67(7):1047. https://doi.org/10.1136/ard.2007.081703
Lawson EF, Trupin L, Yelin EH, Yazdany J (2015) Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum 44(6):666–671. https://doi.org/10.1016/j.semarthrit.2015.01.002
RKI (2015) Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 2015(34). https://doi.org/10.17886/EpiBull-2015-001.2
Goldacker S, Gause AM, Warnatz K, Kommission Pharmakotherapie der DGRh (2013) Vaccination in adult patients with chronic inflammatory rheumatic diseases. Z Rheumatol 72(7):690–704. https://doi.org/10.1007/s00393-013-1155-4
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https://doi.org/10.1002/1529-0131(199709)40:9<1725::AID-ART29>3.0.CO;2-Y
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18(6):800–804. https://doi.org/10.1097/EDE.0b013e3181577654
Barber C, Gold WL, Fortin PR (2011) Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 23(4):358–365. https://doi.org/10.1097/BOR.0b013e3283476cd8
Murdaca G, Orsi A, Spanò F, Faccio V, Puppo F, Durando P et al (2016) Vaccine-preventable infections in systemic lupus erythematosus. Hum Vaccin Immunother 12(3):632–643. https://doi.org/10.1080/21645515.2015.1107685
Chatham WW, Wallace DJ, Stohl W, Latinis KM, Manzi S, McCune WJ et al (2012) Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial. J Rheumatol 39(8):1632–1640. https://doi.org/10.3899/jrheum.111587
Chatham W, Chadha A, Fettiplace J, Kleoudis C, Bass D, Roth D et al (2017) A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus. Lupus 961203317703495. https://doi.org/10.1177/0961203317703495
Nagel J, Saxne T, Geborek P, Bengtsson AA, Jacobsen S, Svaerke Joergensen C et al (2017) Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine. Lupus 961203317695465. https://doi.org/10.1177/0961203317695465
Mathian A, Devilliers H, Krivine A, Costedoat-Chalumeau N, Haroche J, Huong DB et al (2011) Factors influencing the efficacy of two injections of a pandemic 2009 influenza A (H1N1) nonadjuvanted vaccine in systemic lupus erythematosus. Arthritis Rheum 63(11):3502–3511. https://doi.org/10.1002/art.30576
Crowe SR, Merrill JT, Vista ES, Dedeke AB, Thompson DM, Stewart S et al (2011) Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum 63(8):2396–2406. https://doi.org/10.1002/art.30388
Kaur K, Zheng NY, Smith K, Huang M, Li L, Pauli NT et al (2015) High affinity antibodies against influenza characterize the plasmablast response in SLE patients after vaccination. PLOS ONE 10(5):e125618. https://doi.org/10.1371/journal.pone.0125618
Liao Z, Tang H, Xu X, Liang Y, Xiong Y, Ni J (2016) Immunogenicity and safety of influenza vaccination in systemic lupus erythematosus patients compared with healthy controls: a meta-analysis. PLOS ONE 11(2):e147856. https://doi.org/10.1371/journal.pone.0147856
Chang C‑C, Chang Y‑S, Chen W‑S, Chen Y‑H, Chen J‑H (2016) Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus: a nationwide cohort study. Sci Rep 6:37817. https://doi.org/10.1038/srep37817
Siriwardena AN (1999) Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice. Postgrad Med J 75(882):208–212
Bodeker B, Remschmidt C, Muters S, Wichmann O (2015) Influenza, tetanus, and pertussis vaccination coverage among adults in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 58(2):174–181. https://doi.org/10.1007/s00103-014-2097-y
Poethko-Muller C, Schmitz R (2013) Vaccination coverage in German adults: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5):845–857. https://doi.org/10.1007/s00103-013-1693-6
Giat E, Lidar M (2015) Vaccinations in rheumatoid arthritis. In: Shoenfeld Y, Agmon-Levin N, Tomljenovic L (eds) Vaccines & autoimmunity, 1st edn. vol 1. John Wiley & Sons, Hoboken, pp 233–246
Naveau C, Houssiau FA (2005) Pneumococcal sepsis in patients with systemic lupus erythematosus. Lupus 14(11):903–906. https://doi.org/10.1191/0961203305lu2242xx
RKI (2015) Schutzimpfung gegen Masern: Häufig gestellte Fragen und Antworten. http://www.rki.de/SharedDocs/FAQ/Impfen/MMR/FAQ04.html. Accessed 2 May 2016
Krasselt M, Ivanov JP, Baerwald C, Seifert O (2017) Low vaccination rates among patients with rheumatoid arthritis in a German outpatient clinic. Rheumatol Int 37(2):229–237. https://doi.org/10.1007/s00296-016-3608-y
Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA (2005) Factors associated with refusal of childhood vaccines among parents of school-aged children: a case-control study. Arch Pediatr Adolesc Med 159(5):470–476. https://doi.org/10.1001/archpedi.159.5.470
Michel M, Vincent FB, Rio S, Leon N, Marcelli C (2016) Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs. Joint Bone Spine 83(2):237–238. https://doi.org/10.1016/j.jbspin.2015.02.016
Ng B, McBain L, Grainger R (2016) Rheumatologists fail to advise people with RA to get immunised, which matters if you are under 65: an audit in a New Zealand rheumatology service. N Z Med J 129(1446):72–78
Fendler C, Saracbasi E, Dybowski F, Heldmann F, Braun J (2012) Practical problems by implementation of vaccination recommendations. Z Rheumatol 71(2):147–155. https://doi.org/10.1007/s00393-011-0946-8
Ledwich LJ, Harrington TM, Ayoub WT, Sartorius JA, Newman ED (2009) Improved influenza and pneumococcal vaccination in rheumatology patients taking immunosuppressants using an electronic health record best practice alert. Arthritis Rheum 61(11):1505–1510. https://doi.org/10.1002/art.24873
Krasselt M, Baerwald C (2014) The current relevance and use of prednisone in rheumatoid arthritis. Expert Rev Clin Immunol 10(5):557–571. https://doi.org/10.1586/1744666X.2014.904746
Funding
The authors received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
M. Krasselt and O. Seifert declare that they have no competing interests. C. Baerwald received lecture fees from Merck, MSD, Mundipharma and Pfizer.
The ethics committee of the University of Leipzig has approved the design of the study, and written informed consent was obtained from each patient before enrolment.
Additional information
Redaktion
U. Müller-Ladner, Bad Nauheim
U. Lange, Bad Nauheim
Authors’ contributions: M. Krasselt performed the statistical analysis, interpreted the data and drafted the manuscript. C. Baerwald contributed to data interpretation and was involved in manuscript drafting. O. Seifert collected the data, conceived the project and was involved in manuscript preparation. All authors read and approved the final manuscript.
Rights and permissions
About this article
Cite this article
Krasselt, M., Baerwald, C. & Seifert, O. Insufficient vaccination rates in patients with systemic lupus erythematosus in a German outpatient clinic. Z Rheumatol 77, 727–734 (2018). https://doi.org/10.1007/s00393-017-0410-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00393-017-0410-5